Prospective evaluation of 68 Ga-DOTATATE PET/CT in limited disease neuroendocrine tumours and/or elevated serum neuroendocrine biomarkers

68 Ga-DOTATOC Imaging of Neuroendocrine Tumors: A Systematic Review and Metaanalysis

(2017) Michael M. Graham et al.   JOURNAL OF NUCLEAR MEDICINE

Prospective Study of 68Ga-DOTATATE Positron Emission Tomography/Computed Tomography for Detecting Gastro-Entero-Pancreatic Neuroendocrine Tumors and Unknown Primary Sites

(2016) Samira M. Sadowski et al.   JOURNAL OF CLINICAL ONCOLOGY

Molecular Imaging of Gastroenteropancreatic Neuroendocrine Tumors: Current Status and Future Directions

(2016) C. M. Deroose et al.   JOURNAL OF NUCLEAR MEDICINE

Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors

(2016) S. A. Deppen et al.   JOURNAL OF NUCLEAR MEDICINE

68Ga-DOTATATE Compared with 111In-DTPA-Octreotide and Conventional Imaging for Pulmonary and Gastroenteropancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis

(2016) S. A. Deppen et al.   JOURNAL OF NUCLEAR MEDICINE

Comparison of diagnostic accuracy of 111In-pentetreotide SPECT and 68Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours

(2015) S. Van Binnebeek et al.   EUROPEAN RADIOLOGY

Conventional and Nuclear Medicine Imaging in Ectopic Cushing's Syndrome: A Systematic Review

(2015) Andrea M. Isidori et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

68Ga-DOTATOC PET-CT in the localization of source of ectopic ACTH in patients with ectopic ACTH-dependent Cushing's syndrome

(2013) Balasubramanian Venkitaraman et al.   CLINICAL IMAGING

Ectopic ACTH-Secreting Syndrome: A Single-Center Experience

(2013) Harshal Kakade et al.   Endocrine Practice

High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

(2012) Michael S Hofman et al.   Journal of Medical Imaging and Radiation Oncology

The Role of 68Ga-DOTATATE PET in Patients with Neuroendocrine Tumors and Negative or Equivocal Findings on 111In-DTPA-Octreotide Scintigraphy

(2010) R. Srirajaskanthan et al.   JOURNAL OF NUCLEAR MEDICINE

68Ga-DOTA-NOC PET/CT Imaging of Neuroendocrine Tumors: Comparison with 111In-DTPA-Octreotide (OctreoScan®)

(2010) Yodphat Krausz et al.   MOLECULAR IMAGING AND BIOLOGY

One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United States

(2008) James C. Yao et al.   JOURNAL OF CLINICAL ONCOLOGY